Concordia Healthcare Corp. announced consolidated earnings results for the first quarter ended March 31, 2016. For the quarter, revenue was $228,535,000 against $34,113,000 a year ago. The increase was primarily due to $139.9 million of revenue from the Concordia International segment acquired on October 21, 2015 and $56.8 million from the Covis portfolio of products acquired on April 21, 2015, both of which are not included in the comparative period. Operating income was $59,918,000 against $9,805,000 a year ago. Net loss from continuing operations was $4,801,000 against $3,786,000 a year ago. Loss per share, continuing operations - diluted was $0.09 against $0.12 a year ago. Adjusted earnings per share, continuing operations – diluted were $1.35 against $0.54 a year ago. EBITDA was $108,952,000 against $17,840,000 a year ago. Adjusted EBITDA was $140,848,000 against $19,266,000 a year ago.

For fiscal 2016, the company reaffirms guidance, on a constant currency basis, as follows: the company expects revenues of $1,020 million to $1,060 million; adjusted EBITDA of $610 million to $640 million; adjusted net income of $330 million to $355 million; adjusted EPS of $6.29 to $6.77. 2016 guidance assumes that the gross profit targets for the £144 million earn-out payment to the sellers of AMCo will be fully met.